Pharm
Naldemedine
search
Naldemedine
, Symproic
See Also
Gastrointestinal Opioid Antagonist
Opioid Adverse Effect Management
Bowel Regimen in Chronic Narcotic Use
Amatiza (
Lubiprostone
)
Indications
Opioid Induced Constipation
(chronic non-
Cancer Pain
)
Severe refractory
Constipation
due to
Opioid
s
Contraindications
Severe liver disease
Mechanism
Block
Opioid
binding in the intestinal tract
Decreases mu-
Opioid
receptor mediated bowel paralysis
Dosing
Gene
ral
No renal dose adjustment needed
May take with or without food
Take 0.2 mg orally once daily while taking
Opioid
Efficacy
See
Gastrointestinal Opioid Antagonist
Best efficacy in those on
Opioid
s for >4 weeks
Refractory
Opioid Induced Constipation
in Cancer and
Palliative Care
Both oral Naldemedine (Symproic) and SQ
Methylnaltrexone
(
Relistor
) are effective with benefits outweighing harms
Brown (2023) Am Fam Physician 107(2):131-2 [PubMed]
Adverse Effects
Abdominal Pain
Opioid Withdrawal
Safety
Unknown safety in pregnancy
Contraindicated in
Lactation
Drug Interactions
Strong
CYP3A4
inducers
Strong
CYP3A4
Inhibitors
P-Glycoprotein Inhibitor
s
Resources
Naldemedine (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1a1256c-a1eb-4abe-ab1e-30e4711afd16
References
(2017) Presc Lett 24(12): 70
Portenoy (2008) J Pain Symptom Manage 35(5): 458-68 [PubMed]
Thomas (2008) N Engl J Med 358(22): 2332-43 [PubMed]
Type your search phrase here